About Us

Our vision is to provide life-long cures to patients suffering from serious diseases.

Our Values

To achieve our vision, we are continuing to build a strong, values-driven organization focused on our people, advancing cutting-edge science, and rigorously developing a new class of precision genetic medicines. Our values define how we work together:

A community of
fearless innovators

Rigorous and honest
in our research

Listening with
open minds

Committed
to each other

About Us

Executive and Scientific Leadership

John Evans Chief Executive Officer and Board Member

Giuseppe Ciaramella, Ph.D. President and Chief Scientific Officer

Terry-Ann Burrell Chief Financial Officer

Christine Bellon, Ph.D., J.D. Senior Vice President and Chief Legal Officer

Susan O’Connor Chief Human Resources Officer

Courtney Wallace Chief Business Officer

Suzanne Fleming Senior Vice President, Finance

Brian Riley Senior Vice President of Technical Operations

Manmohan Singh, Ph.D. Senior Vice President of Pharmaceutical Sciences and Delivery Technologies

Christine Swenson Senior Vice President of Regulatory Affairs

Francine Gregoire, Ph.D. Vice President for Liver Diseases

Board of Directors

Kristina Burow Board Member

Graham Cooper Board Member

Mark Fishman, M.D. Board Member

Stephen Knight, M.D. Board Member

Robert Nelsen Board Member

Carole Ho, M.D. Board Member

John Evans Chief Executive Officer and Board Member

Kate Walsh Board Member

Founders and Inventors

David R. Liu, Ph.D.

J. Keith Joung, M.D., Ph.D.

Feng Zhang, Ph.D.

Nicole Gaudelli, Ph.D.

Alexis Komor, Ph.D.